Tredje AP fonden Takes Position in Astera Labs, Inc. $ALAB

Tredje AP fonden bought a new position in Astera Labs, Inc. (NASDAQ:ALABFree Report) in the 4th quarter, HoldingsChannel.com reports. The institutional investor bought 31,277 shares of the company’s stock, valued at approximately $5,203,000.

Several other institutional investors have also made changes to their positions in ALAB. Vanguard Group Inc. lifted its position in shares of Astera Labs by 0.6% in the 4th quarter. Vanguard Group Inc. now owns 13,827,506 shares of the company’s stock valued at $2,300,344,000 after acquiring an additional 84,365 shares in the last quarter. State Street Corp raised its stake in Astera Labs by 9.1% during the 3rd quarter. State Street Corp now owns 2,339,451 shares of the company’s stock valued at $458,065,000 after purchasing an additional 195,992 shares during the period. Amundi raised its stake in Astera Labs by 1,298.6% during the 3rd quarter. Amundi now owns 1,421,263 shares of the company’s stock valued at $278,283,000 after purchasing an additional 1,319,643 shares during the period. Value Aligned Research Advisors LLC lifted its holdings in shares of Astera Labs by 16.7% in the third quarter. Value Aligned Research Advisors LLC now owns 1,378,351 shares of the company’s stock valued at $269,881,000 after purchasing an additional 197,320 shares in the last quarter. Finally, BNP Paribas Financial Markets boosted its position in shares of Astera Labs by 577.3% in the third quarter. BNP Paribas Financial Markets now owns 1,127,340 shares of the company’s stock worth $220,733,000 after buying an additional 960,899 shares during the period. 60.47% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In related news, CEO Jitendra Mohan sold 325,693 shares of Astera Labs stock in a transaction on Friday, April 17th. The shares were sold at an average price of $172.14, for a total transaction of $56,064,793.02. Following the completion of the transaction, the chief executive officer owned 4,079,322 shares of the company’s stock, valued at $702,214,489.08. This trade represents a 7.39% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Sanjay Gajendra sold 230,639 shares of the stock in a transaction dated Thursday, May 7th. The stock was sold at an average price of $198.22, for a total value of $45,717,262.58. Following the sale, the chief operating officer owned 664,361 shares of the company’s stock, valued at approximately $131,689,637.42. The trade was a 25.77% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 1,290,546 shares of company stock worth $211,225,088 in the last ninety days. Insiders own 12.50% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts recently issued reports on ALAB shares. Roth Mkm reissued a “buy” rating and issued a $275.00 price objective on shares of Astera Labs in a research note on Wednesday, May 6th. Stifel Nicolaus lifted their price target on shares of Astera Labs from $236.00 to $260.00 and gave the company a “buy” rating in a research report on Wednesday, May 6th. Citigroup upped their price target on shares of Astera Labs from $200.00 to $245.00 and gave the company a “buy” rating in a report on Wednesday, May 6th. Jefferies Financial Group reaffirmed a “buy” rating and set a $270.00 target price on shares of Astera Labs in a research report on Wednesday, May 6th. Finally, Barclays lifted their price objective on Astera Labs from $165.00 to $200.00 and gave the stock an “equal weight” rating in a report on Thursday, May 7th. Fifteen equities research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. According to MarketBeat.com, Astera Labs has a consensus rating of “Moderate Buy” and an average price target of $233.75.

View Our Latest Stock Analysis on ALAB

Astera Labs Price Performance

NASDAQ ALAB opened at $244.26 on Wednesday. Astera Labs, Inc. has a one year low of $84.78 and a one year high of $262.90. The firm has a market cap of $41.87 billion, a P/E ratio of 165.04, a P/E/G ratio of 2.85 and a beta of 3.35. The stock’s 50-day moving average is $159.81 and its 200-day moving average is $157.14.

Astera Labs (NASDAQ:ALABGet Free Report) last posted its earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, topping analysts’ consensus estimates of $0.54 by $0.07. The business had revenue of $308.36 million for the quarter, compared to analyst estimates of $292.19 million. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The firm’s revenue was up 93.5% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.33 EPS. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Equities analysts anticipate that Astera Labs, Inc. will post 1.84 EPS for the current year.

About Astera Labs

(Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

Featured Articles

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALABFree Report).

Institutional Ownership by Quarter for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.